Total Payments
$17,934
2024 Payments
$2,018
Companies
53
Transactions
1,252
Medicare Patients
2,918
Medicare Billing
$319,687
Payment Breakdown by Category
Food & Beverage$17,856 (99.6%)
Education$70.13 (0.4%)
Travel$8.00 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,856 | 1,245 | 99.6% |
| Education | $70.13 | 6 | 0.4% |
| Travel and Lodging | $8.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,305 | 245 | $0 (2024) |
| Lilly USA, LLC | $2,089 | 176 | $0 (2024) |
| Amgen Inc. | $1,429 | 131 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,311 | 91 | $0 (2024) |
| Insulet Corporation | $1,278 | 79 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,270 | 98 | $0 (2024) |
| Abbott Laboratories | $872.18 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $726.48 | 49 | $0 (2020) |
| ABBVIE INC. | $688.51 | 42 | $0 (2024) |
| Corcept Therapeutics | $644.59 | 36 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,018 | 115 | Lilly USA, LLC ($398.15) |
| 2023 | $2,385 | 132 | Lilly USA, LLC ($442.07) |
| 2022 | $2,390 | 151 | Novo Nordisk Inc ($375.02) |
| 2021 | $1,175 | 76 | Novo Nordisk Inc ($412.42) |
| 2020 | $827.49 | 54 | Novo Nordisk Inc ($262.96) |
| 2019 | $2,908 | 233 | Novo Nordisk Inc ($538.04) |
| 2018 | $3,041 | 243 | Novo Nordisk Inc ($564.58) |
| 2017 | $3,189 | 248 | Novo Nordisk Inc ($672.12) |
All Payment Transactions
1,252 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Genetic Disease | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $28.65 | General |
| 12/12/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Insulin Pump | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/02/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.15 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Insulin Pump | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 11/01/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Endocrinology | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/15/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $21.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 761 | 1,117 | $271,737 | $61,166 |
| 2022 | 5 | 632 | 969 | $253,926 | $55,566 |
| 2021 | 5 | 643 | 1,054 | $224,542 | $62,950 |
| 2020 | 11 | 882 | 5,326 | $574,809 | $140,005 |
Total Patients
2,918
Total Services
8,466
Medicare Billing
$319,687
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 430 | 773 | $216,030 | $49,160 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 164 | $27,628 | $7,059 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,253 | $1,903 | 16.9% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 26 | 27 | $6,181 | $1,470 | 23.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 109 | 110 | $8,365 | $1,002 | 12.0% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 14 | 15 | $2,280 | $572.56 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 322 | 642 | $190,244 | $41,893 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 203 | $40,600 | $9,199 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $13,668 | $2,924 | 21.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 17 | 18 | $3,870 | $869.45 | 22.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 72 | 72 | $5,544 | $681.08 | 12.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 341 | 732 | $173,076 | $49,343 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 175 | 193 | $29,623 | $8,814 | 29.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $10,800 | $2,773 | 25.7% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 21 | 23 | $5,167 | $1,288 | 24.9% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 76 | 76 | $5,876 | $732.64 | 12.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 44 | 3,960 | $192,930 | $61,104 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 348 | 720 | $246,360 | $51,995 | 21.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 169 | $44,719 | $8,125 | 18.2% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 79 | 159 | $31,227 | $6,372 | 20.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $15,360 | $3,369 | 21.9% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2020 | 28 | 29 | $10,606 | $2,505 | 23.6% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 64 | 64 | $17,864 | $2,290 | 12.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 30 | 30 | $3,559 | $1,768 | 49.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 51 | 115 | $8,625 | $1,193 | 13.8% |
About Dr. Michael Walker, M.D
Dr. Michael Walker, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659378842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Walker, M.D has received a total of $17,934 in payments from pharmaceutical and medical device companies, with $2,018 received in 2024. These payments were reported across 1,252 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($17,856).
As a Medicare-enrolled provider, Walker has provided services to 2,918 Medicare beneficiaries, totaling 8,466 services with total Medicare billing of $319,687. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Albany, NY
- Active Since 07/01/2005
- Last Updated 03/06/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1659378842
Products in Payments
- Ozempic (Drug) $1,427
- Omnipod (Device) $1,278
- FARXIGA (Drug) $1,204
- JARDIANCE (Drug) $906.68
- Korlym (Drug) $644.59
- INVOKANA (Drug) $640.59
- Repatha (Biological) $549.04
- Victoza (Drug) $541.79
- EVENITY (Biological) $518.74
- AFREZZA (Drug) $484.28
- FREESTYLE LIBRE 3 (Device) $432.42
- Saxenda (Drug) $411.68
- HUMULIN (Drug) $367.46
- TRULICITY (Drug) $339.78
- SOLIQUA (Drug) $336.83
- Prolia (Biological) $330.38
- MOUNJARO (Drug) $317.09
- Rybelsus (Drug) $306.97
- Tymlos (Biological) $263.25
- SOLIQUA 100/33 (Biological) $243.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Albany
Dr. Robert Busch, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4.1M
Endocrinology, Diabetes & Metabolism $4.1M
Dr. Gregg Gerety, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $665,599
Endocrinology, Diabetes & Metabolism $665,599
Dr. Jay Watsky, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $83,103
Endocrinology, Diabetes & Metabolism $83,103
Dr. Mark Fruiterman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,168
Endocrinology, Diabetes & Metabolism $37,168
Dr. Gary Bakst, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,831
Endocrinology, Diabetes & Metabolism $17,831
Dr. Samer Eldeiry, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $9,611
Endocrinology, Diabetes & Metabolism $9,611